Trial · NCT02770807
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | EryDex Low Dose DSP - SAF | 59 | |
| Overall Study | STARTED | EryDex High Dose DSP - SAF | 58 | |
| Overall Study | STARTED | Pooled Placebo - SAF | 59 | |
| Overall Study | Participants Who Took the Study Drug | EryDex Low Dose DSP - SAF | 59 | |
| Overall Study | Participants Who Took the Study Drug | EryDex High Dose DSP - SAF | 57 | |
| Overall Study | Participants Who Took the Study Drug | Pooled Placebo - SAF | 59 | |
| Overall Study | Modified Intention to Treat Population - mITT | EryDex Low Dose DSP - SAF | 56 | |
| Overall Study | Modified Intention to Treat Population - mITT | EryDex High Dose DSP - SAF | 54 | |
| Overall Study | Modified Intention to Treat Population - mITT | Pooled Placebo - SAF | 54 | |
| Overall Study | Safety Population - SAF | EryDex Low Dose DSP - SAF | 59 | |
| Overall Study | Safety Population - SAF | EryDex High Dose DSP - SAF | 57 | |
| Overall Study | Safety Population - SAF | Pooled Placebo - SAF | 59 | |
| Overall Study | Per Protocol Population - PP | EryDex Low Dose DSP - SAF | 36 | |
| Overall Study | Per Protocol Population - PP | EryDex High Dose DSP - SAF | 38 | |
| Overall Study | Per Protocol Population - PP | Pooled Placebo - SAF | 33 | |
| Overall Study | Completed Visit 9 | EryDex Low Dose DSP - SAF | 43 | |
| Overall Study | Completed Visit 9 | EryDex High Dose DSP - SAF | 46 | |
| Overall Study | Completed Visit 9 | Pooled Placebo - SAF | 43 | |
| Overall Study | Discontinued Prior to Visit 9 | EryDex Low Dose DSP - SAF | 16 | |
| Overall Study | Discontinued Prior to Visit 9 | EryDex High Dose DSP - SAF | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02770807/flow